Course Overview
This Continuing Medical Education (CME) activity involves reading a specific issue of Alcohol, Other Drugs, and Health: Current Evidence and then completing a test that will assess your comprehension of the information presented in that issue. To successfully complete this CME activity, clinicians are required to read the entire newsletter, submit the post-test within a designated period of time, and achieve a score of 70% or better.
Accreditation
If your profession is not listed below, please check with your certification board to determine whether you can receive credit for this CME activity. Clinicians who are not eligible to receive credit but successfully complete this activity can receive a certificate of completion.
Physicians
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Boston University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This program is approved for up to 6.0 contact hours of continuing education (CE) credit by the American Academy of Nurse Practitioners (AANP). Participation provides 1 contact hour of CE credit per newsletter. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. Only activities from September 2007 on are eligible for AANP continuing education credit. Program ID 0909305.
Certified Counselors
The CARE Unit, Boston University School of Medicine, is a National Board of Certified Counselors (NBCC)-Approved Continuing Education Provider and offers NBCC-approved clock hours for events that meet NBCC requirements. The CARE, BUSM is solely responsible for all aspects of the program. Approved Provider #6321. Each newsletter is offered for 1 clock hour.
Addictions Counselors
The CARE Unit, Boston University School of Medicine is approved as a Continuing Education Home Study Provider by the National Association of Alcoholism and Drug Abuse Counselors (NAADAC) provider #639. Each newsletter is offered for 1 continuing education hour.
For more information about the Boston University School of Medicine’s Department of Continuing Education, see www.bu.edu/cme.
Target Audience
Generalist clinicians across the United States
Educational Needs Addressed
No existing publication directed at primary care clinicians focuses on the spectrum of health issues related to alcohol and other drugs. Further, current publications that summarize research commonly do not serve the needs of practicing generalist clinicians. These publications are too long for busy clinicians, are often available by paid subscription only, cannot be copied, are not tailored to primary care clinicians, and are not distributed on the web. An evidence-based newsletter that is distributed by a well-established and accessible technology will contribute substantially to the dissemination of research findings into clinical primary care practice.
By creating and distributing this evidence-based newsletter, we hope to raise the “status” of alcohol and drug problems in both academic and clinical practice culture. Primary care clinicians often miss the diagnosis of alcohol or drug problems. Also, because of the effects of alcohol and drugs on adherence to medical care and physician-patient relationships, patients with alcohol or drug problems may receive less than adequate treatment for other conditions. Furthermore, physicians sometimes perceive alcohol or drug dependence as less satisfying to treat and less treatable than other medical conditions, and thus delegate responsibilities for screening and intervention to others. A research-based newsletter will emphasize the importance of addressing alcohol and drug issues and provide information of the same quality to which physicians have become accustomed for other illnesses such as asthma, heart disease, diabetes, and cancers.
Program Learning Objectives
At the conclusion of this program, participants will be able to state the latest research findings on alcohol, illicit drugs, and health; incorporate the latest research findings on alcohol, illicit drugs, and health into their clinical practices, when appropriate; and recognize the importance of addressing alcohol and drug problems in primary care settings.
Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Course Faculty
Richard Saitz, MD, MPH, FASAM, FACP
Course Director
Professor of Medicine and Epidemiology
Associate Director,Youth Alcohol Prevention Center
Director, Clinical Addiction Research and Education (CARE) Unit
Section of General Internal Medicine
Boston Medical Center
Boston University Schools of Medicine and Public Health
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
David A. Fiellin, MD
Associate Professor of Medicine
Section of General Internal Medicine
Yale University School of Medicine
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Nicolas Bertholet, MD, MSc
Center for Alcohol Treatment
Department of Medicine and Public Health
Lausanne University, Switzerland
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
R. Curtis Ellison, MD
Professor of Medicine and Public Health
Chief, Section of Preventive Medicine and Epidemiology
Evans Department of Medicine
Director, Institute on Lifestyle and Health
Boston University School of Medicine
Faculty member is the Director of the Institute on Lifestyle and Health, which receives various donations from individuals and companies in the alcohol beverage industry, given as "unrestricted educational gifts." Funds are not given for specific research projects and donors have no prior information on, or input into, the surveillance being carried out or critiques published by the Institute or the Section. Faculty member does not discuss unlabeled/investigational uses of a commercial product.
Peter D. Friedmann,
MD, MPH
Associate Professor of Medicine and Community Health
Director, Program to Integrate Psychosocial and Health Services in Chronic Disease and Disability
Providence VA Medical Center
Division of General Internal Medicine
Rhode Island Hospital
Warren Alpert Medical School of Brown University
Faculty member serves on the Speakers Bureau of Reckitt Benckiser, is a stockholder in Alkermes, Inc, and has consulted for Clinical Tools. Faculty member does not discuss unlabeled/investigational uses of a commercial product.
Marc N. Gourevitch, MD, MPH
Dr. Adolph and Margaret Berger Professor of Medicine
Director, Division of General Internal Medicine
New York University School of Medicine
Faculty member received grant/research support from Cephalon. Faculty member does not discuss unlabeled/investigational uses of a commercial product.
Kevin L. Kraemer,
MD, MSc
Associate Professor of Medicine and Health Policy and Management
Director, General Internal Medicine Fellowship Program
Division of General Internal Medicine
University of Pittsburgh Schools of Medicine and Public Health
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Hillary Kunins, MD, MPH, MS
Associate Clinical Professor of Medicine and
Psychiatry & Behavioral Sciences
Albert Einstein College of Medicine
Faculty member is a stockholder in Pfizer, Abbott Laboratories, Johnson & Johnson, and Medtronic, Inc. Faculty member does not discuss unlabeled/investigational uses of a commercial product.
Darius A. Rastegar, MD
Assistant Professor of Medicine
Johns Hopkins School of Medicine
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Jeffrey H. Samet,
MD, MA, MPH
Professor of Medicine and Social and Behavioral Sciences
Chief, Section of General Internal Medicine
Boston Medical Center
Boston University Schools of Medicine and Public Health
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Jeanette M. Tetrault, MD
Assistant Professor of Internal Medicine
Yale University School of Medicine
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Alexander Y. Walley,
MD, MSc
Instructor of Medicine
Boston Medical Center
Boston University School of Medicine
Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Donna Vaillancourt
Managing Editor
Alcohol, Other Drugs, and Health: Current Evidence
Boston Medical Center
Staff member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.
Privacy Policy
The Office of Continuing Medical Education adheres to Boston University’s Conditions of Use and Policy on Computing Ethics.
Data gathered from participants who participate in Boston University School of Medicine’s (BUSM) Continuing Medical Education Internet-Based CME program is confidential.
Individual identifiable information is not shared with outside parties. Cumulative data may be analyzed by CME personnel, and upon occasion, by individuals external to BUSM CME, in order to determine trends.
Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
Sponsored by the Boston University School of Medicine
©Trustees of Boston University 2008
